235 results on '"Bartkowiak, D."'
Search Results
2. Analysis Of Nrs-2002 Scale Results Performed On The First Day Of Hospitalization After The Surgery.
3. Adjuvante Strahlentherapie beim lymphknotenpositiven Prostatakarzinom mit geringer Tumorlast nach radikaler Prostatektomie: Multizentrische randomisierte Phase-III-Studie zur Wirkung einer adjuvanten Strahlentherapie bei Patienten mit Prostatakarzinom mit oder ohne positiven Schnittrand nach radikaler Prostatektomie (RP) und Lymphknotenmetastasierung mit geringer Tumorlast (Mikrometastasen, ≤ 2 Lymphknotenmakrometastasen). ART-2 – Studie AP 61/10 der AUO
4. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics
5. Toxicity profile of immediate post-prostatectomy radiation therapy: results from a large multi-institutional series
6. Strahlentherapie beim nodal-positiven Prostatakarzinom
7. Die neue EAU-BCR Risikoklassifizierung als Entscheidungshilfe für Salvage Radiotherapie
8. Adjuvante Strahlentherapie beim lymphknotenpositiven Prostatakarzinom mit geringer Tumorlast nach radikaler Prostatektomie: Multizentrische randomisierte Phase-III-Studie zur Wirkung einer adjuvanten Strahlentherapie bei Patienten mit Prostatakarzinom mit oder ohne positiven Schnittrand nach radikaler Prostatektomie (RP) und Lymphknotenmetastasierung mit geringer Tumorlast (Mikrometastasen, ≤ 2 Lymphknotenmakrometastasen). ART-2-Studie AP 61/11 der AUO
9. Absence of Inflammatory Response from Upper Airway Epithelial Cells after X Irradiation
10. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics
11. PSA doubling time as predictor of relapse after early salvage radiation therapy: When should imaging be used to select patients who might not benefit from early local treatments?
12. Verbundprojekt ESKaRa
13. The key role of PSA doubling time in patients treatedwith salvage radiation therapy after radical prostatectomy: implications for the extent of radiation and the concomitant use of hormonal therapy
14. Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treatedwith post-prostatectomy radiation therapy: results from a large, multi-institutional study
15. Very long term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: implications for risk tailored follow-up strategies
16. What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 prostate cancer? Results form a large multi-institutional series
17. There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy. a retrospective, multi-centre analyses on oncological and toxicity outcomes
18. Radiotherapy after radical prostatectomy: immediate or early delayed?
19. What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 Prostate Cancer? Results form a large Multi-Institutional series
20. The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: Implications for the extent of radiation and the concomitant use of hormonal therapy
21. Very long-term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: Implications for risk tailored follow-up strategies
22. Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing?
23. Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treated with post-prostatectomy radiation therapy: Results from a large, multi-institutional study
24. On the Structure-Bounded Growth Processes in Plant Populations
25. The General Growth Logistics of Cell Populations
26. Stationary cell size distributions and mean protein chain length distributions of Archaea, Bacteria and Eukaryotes described with an increment model in terms of irreversible thermodynamics
27. PD-0671: Matched pair analysis of salvage radiotherapy vs observation for post-prostatectomy PSA recurrence
28. Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large multi-institutional series
29. Assessing the impact of salvage radiation therapy field after radical prostatectomy: a long-term analysis from a large multi-institutional series
30. Changing patterns and predictors of salvage radiation therapy use over time in patients treated for post-prostatectomy biochemical recurrence: a trend analysis over a 20-year period from a multi institutional series
31. Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: a stage-specific analysis from a large multi-institutional series
32. Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
33. Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: A stage-specific analysis from a large multi-institutional series
34. Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series
35. EAU BCR risk classification as decision tool for salvage radiatiotherapy
36. Salvage radiotherapy versus observation for biochemical recurrence following radical prostatectomy for prostate cancer: A matched pair analysis
37. Choline PET/CT for detecting of local recurrence in prostate cancer: PO603
38. Sorption of precious metals from acid solutions by functionalised vinylbenzyl chloride–acrylonitryle–divinylbenzene copolymers bearing amino and guanidine ligands
39. SC93 - Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics
40. SC94 - Toxicity profile of immediate post-prostatectomy radiation therapy: results from a large multi-institutional series
41. PT079 - Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study
42. Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
43. There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
44. Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
45. What is the best definition of biochemical response to salvage radiation therapy in prostate cancer patients treated for PSA rising after radical prostatectomy? Results from a multi-institutional series
46. There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
47. SC199 - There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy. a retrospective, multi-centre analyses on oncological and toxicity outcomes
48. SC198 - Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treatedwith post-prostatectomy radiation therapy: results from a large, multi-institutional study
49. SC201 - The key role of PSA doubling time in patients treatedwith salvage radiation therapy after radical prostatectomy: implications for the extent of radiation and the concomitant use of hormonal therapy
50. SC200 - Very long term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: implications for risk tailored follow-up strategies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.